Inventor · disambiguated record
Amanda Proudfoot
Also filed as: PROUDFOOT AMANDA · PROUDFOOT AMANDA E I
18 granted patents·5 pending applications·45 citations·filing 1995–2022
91Inventor score
Top patents by PatentIndex Score
23 records- 0180US10829552B2Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and methods of treatment using sameMERCK PATENT GMBH·Filed 2018·Granted Nov 10, 2020·1 cites·14 claims
- 0276US10017568B2Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and method of treatment using sameROMMELAERE HEIDI·Filed 2012·Granted Jul 10, 2018·3 cites·13 claims
- 0374US2022195031A1Amino acid sequences directed against il-17a, il-17f and/or il-17a/f and polypeptides comprising the sameMERCK PATENT GMBH·Filed 2022·Application pending·0 cites
- 0472US11773159B2Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and methods of treatment using sameMERCK PATENT GMBH·Filed 2020·Granted Oct 3, 2023·0 cites·15 claims
- 0571US6555105B1Method of treatment with a RANTES antagonist polypeptideGLAXO GROUP LTD·Filed 2000·Granted Apr 29, 2003·4 cites·12 claims
- 0670US6159711ADNA encoding rantes peptide fragments and methods of treatment with the fragmentsGLAXO GROUP LTD·Filed 1995·Granted Dec 12, 2000·23 cites·10 claims
- 0769US7541435B2Antagonists of cxcr3-binding cxc chemokinesMERCK SERONO SA·Filed 2003·Granted Jun 2, 2009·4 cites·23 claims
- 0865US7740833B2Therapeutic uses of chemokine variantsMERCK SERONO SA·Filed 2004·Granted Jun 22, 2010·5 cites·12 claims
- 0963US7393660B2CC-chemokine binding tick proteinsSERONO LAB·Filed 2004·Granted Jul 1, 2008·2 cites·28 claims
- 1062US7402303B2Chemokine mutants in the treatment of multiple sclerosisSERONO LAB·Filed 2001·Granted Jul 22, 2008·1 cites·2 claims
- 1162US7335350B2Chemokines mutants having improved oral bioavailabilitySERONO LAB·Filed 2003·Granted Feb 26, 2008·1 cites·3 claims
- 1260US7553483B2Chemokine mutants acting as chemokine antagonistsMERCK SERONO SA·Filed 2002·Granted Jun 30, 2009·1 cites·20 claims
- 1353US7670802B2CXC-chemokine antagonists isolated from Rhipicephalus sanguineusMERCK SERONO SA·Filed 2006·Granted Mar 2, 2010·0 cites·23 claims
- 1448US7611867B2CC-chemokine binding tick proteinsMERCK SERONO SA·Filed 2007·Granted Nov 3, 2009·0 cites·31 claims
- 1545US7803910B2Soluble CD164 polypeptidesMERCK SERONO SA·Filed 2006·Granted Sep 28, 2010·0 cites·8 claims
- 1644US7476381B2Methods of reducing serum alanine transferase levels in a subject with hepatitisSERONO LAB·Filed 2003·Granted Jan 13, 2009·0 cites·6 claims
- 1744US2009022657A1Novel CXCL8 antagonistsAPPLIED RESEARCH SYSTEMS·Filed 2004·Application pending·0 cites
- 1843US7635576B2CC-chemokine binding tick proteinsMERCK SERONO SA·Filed 2005·Granted Dec 22, 2009·0 cites·30 claims
- 1941US2008193414A1Use of an Immunoglobulin Domain-Containing Cell Surface Recognition Molecule For Treating DiseasesPROUDFOOT AMANDA·Filed 2006·Application pending·0 cites
- 2038US7425324B2Antagonists of MCP proteinsSERONO LAB·Filed 2003·Granted Sep 16, 2008·0 cites·28 claims
- 2138US2008253996A1Use of Sdf-1 for the Treatment and/or Prevention of Neurological DiseasesSERONO LAB·Filed 2006·Application pending·0 cites
- 2236US2008299072A1Chemokine AntagonistsSERONO LAB·Filed 2006·Application pending·0 cites
- 2324US6902728B1Chemokine receptor antagonist and cyclosporin in combined therapyAPPLIED RESEARCH SYSTEMS·Filed 1999·Granted Jun 7, 2005·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Amanda Proudfoot files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →